Market Trends of Filter Integrity Test Industry
This section covers the major market trends shaping the Filter Integrity Test Market according to our research experts:
Automated Segment is Expected to Witness Growth Over the Forecast Period
Filter integrity testing is done to ensure that the final product is free of contamination. This involves examining the disc filters, capsules/cartridges, and filter membranes for integrity. Automated integrity test systems or machines are available in either a standalone or networkable configuration and offer reliable, repeatable integrity test data as opposed to manual filter integrity tests. Thus, owing to such an advantage, the demand for automated systems is expected to increase, further fueling the segment's growth.
Few of the commercially available automated systems provide better reliability. Merck Millipore's Integritest 4 series automated filter integrity test instrument, for example, features an intuitive touch screen and user interface that streamlines the test process and accelerated testing capability that gives users more time for processing. Additionally, on-site calibration support and the diagnostic capability of the machine minimize downtime, saving time and money.
In addition, several other automated systems available on the market perform various filter integrity tests. For example, the Sartocheck 5 Plus Filter Tester is an automatic filter integrity tester that can test everything from small syringe filters to large multi-round housings and tangential flow cassettes. This is prepared for automated cleaning of all pneumatics as well. Thus, the availability of such advanced automated machines is driving the segment's growth.
Therefore, due to the market's availability of advanced automated systems, the segment is expected to witness growth over the forecast period.
North America is Anticipated to Witness Growth Over the Forecast Period
North America is holding the largest share of the market, and it is expected to maintain its stronghold over the analysis period. Factors such as high R&D expenditure and increasing innovation and development of biopharmaceuticals across the countries of the region are majorly attributed to the growth of the market in North America.
Before batch processing, filter integrity is monitored during integrity testing of sterilizing filters, preventing the use of a non-integral filter. After a batch of filters has been sterilized, their integrity can be tested to see if it has been compromised. Thus, with the increasing demand for pharmaceuticals and biopharmaceuticals, R&D expenditure is also expected to augment in the United States and other countries across the region, ultimately driving the studied market growth. As per the data updated by PhRMA member companies' annual survey data released in July 2022, PhRMA member companies invested USD 102.3 billion in R&D in 2021, the highest level of investment ever made in the United States.
Furthermore, the spending on R&D by various pharmaceutical companies along with government organizations has been increasing recently across the countries in Canada, which is anticipated to drive market growth in the region. For instance, the government and private sectors are heavily investing in pharmaceutical drugs. The November 2021 update by CIHI shows that healthcare expenditure was USD 230,005 million by the public sector and USD 78,038.3 million by the private sector in 2021, which increased from USD 226,246.5 million and USD 75,208.3 million by the public and private sectors, respectively, in 2020. Thus, this increasing healthcare expenditure in the country is predicted to impact the demand for biopharmaceuticals, in turn boosting productivity across the facilities that make use of filters for GMP.
In addition, as per the source above, in-house spending on R&D is estimated to grow by 3.5%, reaching USD 23.4 billion in 2021. While the companies expect modest growth in their in-house R&D spending in 2022, total R&D spending is expected to increase by 1.7% to USD 23.8 billion (estimated). Thus, these increasing investments by governments across Canada are creating demand for the development of advanced drugs for various purposes. This is fueling the demand for filter integrity tests to check drug safety and efficacy. Hence, it is anticipated to drive the studied market's growth.
Therefore, owing to an increase in investments, North America is expected to hold a major market share over the forecast period.
